31 P-MRS muscolo scheletrico

46
P-MRS muscolo scheletric Glicogenolisi e glicolisi Metabolismo ionico rasporto del Pi nel mitocondrio Efflusso di H + dal citosol Respirazione mitocondriale H intracellulare (citosolico) [Mg 2+ ] libero del citosol G ATP idrolisi

description

31 P-MRS muscolo scheletrico. Respirazione mitocondriale. Glicogenolisi e glicolisi. pH intracellulare (citosolico). [Mg 2+ ] libero del citosol. Metabolismo ionico. Trasporto del Pi nel mitocondrio. Efflusso di H + dal citosol. D G ATP idrolisi. ATP + H 2 O. ADP + Pi. functional - PowerPoint PPT Presentation

Transcript of 31 P-MRS muscolo scheletrico

Page 1: 31 P-MRS  muscolo scheletrico

31P-MRS muscolo scheletrico

Glicogenolisi e glicolisi

Metabolismo ionicoTrasporto del Pi nel mitocondrio

Efflusso di H+ dal citosol

Respirazione mitocondriale

pH intracellulare (citosolico)[Mg2+] libero del citosol

G ATP idrolisi

Page 2: 31 P-MRS  muscolo scheletrico

ATP + H2O ADP + Pi functional ATPases

PiPCr [ADP]

PCr + ADP + H+ Cr + ATP Creatine kinase

PCr + H2O Cr + Pi sum

Page 3: 31 P-MRS  muscolo scheletrico

Stress metabolico

Page 4: 31 P-MRS  muscolo scheletrico
Page 5: 31 P-MRS  muscolo scheletrico
Page 6: 31 P-MRS  muscolo scheletrico
Page 7: 31 P-MRS  muscolo scheletrico

Esercizio muscolare

Respirazione mitocondriale

Glicogenolisi

Trasporto del Pi nel mitocondrio

Glicolisi

Page 8: 31 P-MRS  muscolo scheletrico

PCr + ADP + H+

Cr + ATP

Page 9: 31 P-MRS  muscolo scheletrico

6.70

6.80

6.90

7.00

7.10cy

toso

lic p

H

60 1200recovery time (s)

rest

work recovery

Page 10: 31 P-MRS  muscolo scheletrico

Recupero dall’esercizio

Respirazione mitocondriale

Glicogenolisi

Trasporto del Pi nel mitocondrio

Glicolisi

Page 11: 31 P-MRS  muscolo scheletrico
Page 12: 31 P-MRS  muscolo scheletrico

60 120 180 24000

40

20

10

30

Tempo di recupero (s)

(uni

otà

arb

itra

rie M

RS

) PCrLivello a riposoa

b ultimo livello di lavoro

Y = a (1 – e )-

TC

t

TC = 26 s

[PC

r]

Page 13: 31 P-MRS  muscolo scheletrico

PC

r (m

M)

Glycolytic test

0

10

CUFF ON OFF

REST RECOVERY30

20

WORK

9630 15time (min)

Page 14: 31 P-MRS  muscolo scheletrico

60 120 180 24000

40

20

10

30

Recovery time (s)

MR

S a

rbitr

ary

units

Pi resting level

b last level of work

Y = b e -

TC

t

TC = 28 s

[Pi]

Page 15: 31 P-MRS  muscolo scheletrico

6.70

6.80

6.90

7.00

7.10cy

toso

lic p

H

60 1200recovery time (s)

rest

work recovery

minimum pH

Page 16: 31 P-MRS  muscolo scheletrico

PCr + ADP + H+

ATP + Cr

Page 17: 31 P-MRS  muscolo scheletrico

ATP + Cr PCr + ADP + H+

Page 18: 31 P-MRS  muscolo scheletrico

6.70

6.80

6.90

7.00

7.10cy

toso

lic p

H

60 1200recovery time (s)

rest

work recovery

418 J/min

270 J/min

minimum pH

Page 19: 31 P-MRS  muscolo scheletrico
Page 20: 31 P-MRS  muscolo scheletrico

La velocità di recupero di PCr e di Pi sonoinversamente proporzionali al valore di pH

carrier mitocondriale di Pi(rate limiting)

Driving force: gradiente di pH (pH 8.0 matrice; pH 6.0 citosol)

bassa KM for HPO42-

Affinità del Carrier:(pK2 = 6.68)

Page 21: 31 P-MRS  muscolo scheletrico

6.2 6.4 6.6 6.8 7.0Minimum pH

0

20

60

40

80T

C P

i (s)

(ra

te o

f PC

r re

cove

ry)

Reference range(95% confidence interval)

Page 22: 31 P-MRS  muscolo scheletrico

calf muscle 31P MRS in DMD/BMD carriers

Page 23: 31 P-MRS  muscolo scheletrico

Condizioni per la valutazione della velocità di recupero di PCr dall’esercizio

pH minimo minore di 6,90

Eccesso di substrati:

Alto ADP (> 60 M)Alto Pi (> 25 mM)Alto O2 (iperemia)

__________

Page 24: 31 P-MRS  muscolo scheletrico

6.2 6.4 6.6 6.8 7.0Minimum pH

0

20

60

40

80T

C P

Cr

(s)

(ra

te o

f PC

r re

cove

ry)

Reference range(95% confidence interval)

Page 25: 31 P-MRS  muscolo scheletrico

6.2 6.4 6.6 6.8 7.0Minimum pH

0

20

60

40

80T

C P

Cr

(s)

(ra

te o

f PC

r re

cove

ry)

Reference range(95% confidence interval)

mtDNA mutation at bp 117788

Page 26: 31 P-MRS  muscolo scheletrico

0

6.2 6.4 6.6 6.8 7.0Minimum pH

20

60

40

80T

C P

Cr

(s)

(ra

te o

f PC

r re

cove

ry)

Reference range(95% confidence interval)

case 1

case 2case 3

before training

after training

Page 27: 31 P-MRS  muscolo scheletrico

Chronic Progressive External Ophtalmoplegia (CPEO) mtDNA deletion/s (Cox deficit), RRF

Leber’s Hereditary Optic Neuropathy (LHON) 11778 bp mtDNA mutation (Complex I)

Mitochondrial myopathy (MM) mtDNA deletion/s (Cox / SDH deficit), RRF

Mitochondrial encephalomyopathies MEMMELAS (3243 mtDNA mutation (tRNA-leu), RRF, SCR deficit,)MERRF (Myoclonal epilespsy w. RRF) - 8993 mtDNA mutation (tRNA-lys), RRF

mitochondrial cytopathies

Page 28: 31 P-MRS  muscolo scheletrico
Page 29: 31 P-MRS  muscolo scheletrico
Page 30: 31 P-MRS  muscolo scheletrico

CPEO (Cox deficit) control

Page 31: 31 P-MRS  muscolo scheletrico

normal control MELAS patient

PCr

Pi

Page 32: 31 P-MRS  muscolo scheletrico

2 3 4 5 76

resting Pi (mM)

patients

controls

reference values (95% confidence interval)

4.822.43

Page 33: 31 P-MRS  muscolo scheletrico

60 120 180 24000

40

20

10

30

Recovery time (s)

PC

r re

cove

ry

(M

RS

arb

itrar

y un

its) Control

TC = 38s; pH = 6.58

TC = 58s; pH = 6.62

CPEO (Cox deficit)

Page 34: 31 P-MRS  muscolo scheletrico

6.2 6.4 6.6 6.8 7.0Minimum pH

Reference range(95% confidence interval)

0

20

60

40

80

TC

PC

r (s

) (r

ate

of P

Cr

reco

very

)

100

Page 35: 31 P-MRS  muscolo scheletrico

Multiple logistic regression applied to two independent indicators:

1. [Pi] at rest,

2. rate of PCr recovery

PrD (probability of disease) = 1 + e -(0.538 * Ds + 4.312 P – 23.729)

1

Ds = rate of PCr recovery (sec) P = [Pi] at rest

Page 36: 31 P-MRS  muscolo scheletrico

Rest only 15/31 48.4 %

Recovery only 26/31 83.9 %

Assessment conditionMuscle abnormality

revealed by 31P-MRS

Analysis by multiple logistic regression 31/31 100.0 %

SENSITIVITY 100%; SPECIFICITY 100%

Page 37: 31 P-MRS  muscolo scheletrico

HEADACHE(over 120 patients studied)

(brain – occipital lobes)

Complicated migraine 2.91 + 0.25 39.5

Migraine with aura 3.73 + 0.30 55.3

Migraine withot aura 3.39 + 0.30 50.3

Cluster headache 3.54 + 0.36 52.1Healty volunteers 4.45 + 0.27 83.7

[Phosphocreatine] (mM)

Phosphorylation potential (mM-1)

Failure of mitochondrial energy transductions in the brain of all patiens with headache is a favouring background for the triggering of headache

Page 38: 31 P-MRS  muscolo scheletrico

HEADACHE(over 120 patients studied)

skeletal muscle (gastrocnemius)

The rate of PCr recovery after exercise is a measure of mitochondrial funtionality

dashed area defines the reference interval

Failure of skeletal muscle energy tranductions lead us to put forward the hypothesis that headache is a systemic disease primarely involving energy metabolism

A = MS; B = MwA; C = MwoA; D = CH

Page 39: 31 P-MRS  muscolo scheletrico

Glicogenosi muscolari

Page 40: 31 P-MRS  muscolo scheletrico

McArdleUDPG PLD

glycogen

glucose-1-P

glucose-6-P

fructose-6-P

fructose-1,6-P

glycerldehyde-3-P (2)

3-P-glyceroyl phosphate (2)

3-P-glycerate (2)

2-P-glycerate (2)

Phosphoenolpyruvate (2)

Pyruvate (2)

Lactate (2)

Page 41: 31 P-MRS  muscolo scheletrico

Deficit di PFKUDPG PLD

glycogen

glucose-1-P

glucose-6-P

fructose-6-P

fructose-1,6-P

glycerldehyde-3-P (2)

3-P-glyceroyl phosphate (2)

3-P-glycerate (2)

2-P-glycerate (2)

Phosphoenolpyruvate (2)

Pyruvate (2)

Lactate (2)

patient control

No pH variation during work and recovery

Page 42: 31 P-MRS  muscolo scheletrico

Deficit di PGAMUDPG PLD

glycogen

glucose-1-P

glucose-6-P

fructose-6-P

fructose-1,6-P

glycerldehyde-3-P (2)

3-P-glyceroyl phosphate (2)

3-P-glycerate (2)

2-P-glycerate (2)

Phosphoenolpyruvate (2)

Pyruvate (2)

Lactate (2)

controllo paziente

No pH variation during work and recovery

Page 43: 31 P-MRS  muscolo scheletrico

Valutazione dell’effetto della terapia

trattamento con CoQ pazienti con citopatie mitocondriali

Page 44: 31 P-MRS  muscolo scheletrico
Page 45: 31 P-MRS  muscolo scheletrico

Reference range

6.5 6.7 7.1

minimum pH

6.9

TC

PC

r (s

)

20

40

80

60

100

0

6

7

9

51

23

4

108

oral CoQ (150 mg/day)for 6 months

Mitochondrialmyopathies

Page 46: 31 P-MRS  muscolo scheletrico

31P MRS

Abnormal

BLOOD ANALYSISBiochemistry, molecular geneticMUSCULAR BIOPSY Histochemistry, biochemistry, molecular genetic

Normal

Symptoms and clinical examination suggesting

metabolic myopathy

31P MRS

Diagnosis confirmation

Therapy follow-upAssessment of evolution

Screening of families

Bicycle exercise test Ischaemic test

EMG